4/A

PRIMARY DOCUMENT

Company: TENAX THERAPEUTICS, INC.
Filed: August 9, 2011
Period of Report: October 8, 2010
Accession Number: 0001481435-11-000005

View Document ↗ View on SEC.gov ↗